StockData
Arbutus Biopharma Corp logo

Arbutus Biopharma Corp (ABUS) stock

ABUSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 14/3073% below fair value
$4.05+0.01 (+0.25%)

Close on Nov 17, 2026Market cap $801.28MP/E 5.2Yield –

Arbutus Biopharma pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Arbutus Biopharma's pe ratio was 5.0× on Nov 11, 2026, against 2.6× a year earlier.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20265.0×−1.8
2014Jan 31, 20146.7×+2.9
2013Dec 31, 20133.9×–

More Arbutus Biopharma figures

See a number that looks wrong?